Yes, the BiPAP Settings Should Be Adjusted
This patient requires BiPAP adjustment because the residual AHI of 16.3 events/hour indicates inadequate control of obstructive sleep apnea, and the maximum leak of 114.8 L/min is unacceptably high and likely contributing to treatment failure. 1
Two Critical Problems Requiring Intervention
Problem 1: Inadequate OSA Control (Residual AHI 16.3)
The current residual AHI of 16.3 events/hour represents moderate OSA despite therapy. According to AASM guidelines, optimal NPPV/BiPAP titration should achieve:
- RDI (respiratory disturbance index) < 5/hour for optimal control 1
- RDI < 10/hour is considered merely "adequate" 1
This patient's residual AHI of 16.3 falls well short of treatment goals, indicating the current pressures are insufficient to maintain upper airway patency throughout the night.
Problem 2: Excessive Leak
The maximum leak of 114.8 L/min is unacceptably high. Guidelines define unacceptable leak as one "significantly higher than the leak resulting from a given mask fitted securely in place at the current pressure settings" 1. High leak has two critical consequences:
- Reduces therapeutic efficacy: Even though BiPAP devices are leak-tolerant, high leak reduces the ability of pressure support to augment tidal volume and maintain adequate ventilation 1
- Causes arousals and sleep fragmentation: Substantial leak (particularly mouth leak) causes arousals even when the device attempts to maintain desired pressures 1
Recommended Action Algorithm
Step 1: Address the Leak FIRST (Priority)
Before adjusting pressures, the leak must be corrected 1:
- Mask refit/readjustment: Ensure proper mask fit and seal
- Consider mask type change: Switch to different interface if current mask continues to leak
- Assess for mouth leak: If using nasal mask:
- Add chin strap, OR
- Switch to full-face/oronasal mask 1
- Check for pressure-related leak: High leak may indicate the maximum IPAP duration is too long, causing delayed cycling to EPAP 1
Step 2: Increase Pressures to Control Residual Events
Once leak is addressed, titrate pressures upward 2:
- Increase IPAP incrementally (typically by 1-2 cm H₂O) to eliminate residual apneas, hypopneas, RERAs, and snoring
- Maintain or adjust EPAP as needed to prevent airway collapse during expiration
- Target: Residual AHI < 5/hour 1
The current IPAP of 14 cm H₂O is likely insufficient given the residual AHI of 16.3.
Step 3: Consider Comfort Settings Optimization
If the patient reports discomfort with higher pressures 1:
- Adjust rise time: For OSA patients (obstructive airway disease), shorter rise times (100-400 ms) are often preferred
- Adjust maximum IPAP duration: May need to be decreased if excessive leak is causing delayed cycling
- Consider pressure relief features: If available and patient complains of difficulty exhaling
Step 4: Arrange Formal Re-titration
Given both inadequate control AND excessive leak, in-laboratory BiPAP re-titration is strongly recommended 2. This allows:
- Real-time leak management
- Precise pressure optimization
- Assessment during REM sleep in supine position (when OSA is typically worst)
- Verification that oxygen saturation remains >90% 1
Common Pitfalls to Avoid
Do not ignore the leak: Attempting to increase pressures without first addressing leak will worsen the leak and fail to improve AHI 1
Do not accept residual AHI >10: This patient's AHI of 16.3 represents ongoing moderate OSA with continued cardiovascular and neurocognitive risk
Do not assume good compliance equals good control: This patient has excellent usage (7 hrs 41 min nightly, 97% compliance), but compliance without adequate pressure control provides minimal benefit
Do not delay intervention: Persistent untreated OSA (even with device usage) continues to cause intermittent hypoxia, sympathetic activation, and sleep fragmentation, negating the benefits of therapy
Expected Outcome After Adjustment
With proper leak management and pressure optimization, expect:
- Residual AHI < 5/hour
- Leak reduced to acceptable levels (typically <24 L/min for most interfaces)
- Maintained excellent compliance
- Improved sleep quality and daytime symptoms